http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110283165-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
filingDate | 2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110283165-B |
titleOfInvention | 4-Phenoxyquinolino α-acyloxyamide compounds and preparation method and use thereof |
abstract | The present invention relates to a 4-phenoxyquinolino α-acyloxy amide compound I, and the 4-phenoxyquinolino α-acyloxy amide compound I is used as a tyrosine kinase inhibitor, in particular is a c-Met inhibitor. The present invention also relates to a preparation method for preparing such compounds; the present invention further relates to a compound I containing 4-phenoxyquinoline α-acyloxy amides as a medicine for the treatment of diseases related to tyrosine kinase c-Met , in particular the use of c-Met-related cancers. |
priorityDate | 2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.